Liver Diseases: all 2,094 studies
Page 20 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Double-blind Randomized Controlled Trial in Severe Alcoholic HepatitisCompletedNCT01214226Phase 3
- Trial of Hepaguard® in Adults With Nonalcoholic SteatohepatitisCompletedNCT01210989Not applicable
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)CompletedNCT01208649Phase 4
- ¹³C-Methacetin Breath Test (MBT) Methodology StudyStatus unknownNCT01205074Phase 2/3
- Sulfation of Bile Acids as a Biomarker for Hepatobiliary DiseasesTerminatedNCT01200082
- Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.CompletedNCT01195181Phase 4
- Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver DiseaseWithdrawnNCT01191177Phase 1/2
- A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941CompletedNCT01187186Phase 1
- Effect of Intermittent Hepatic Inflow Occlusion During Donor Hepatectomy In Living Donor Liver TransplantationStatus unknownNCT01171742Phase 3
- Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)Status unknownNCT01169168
- A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT01167088Phase 2
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Everolimus and LongActing Octreotide Trial in Polycystic LiversCompletedNCT01157858Phase 2
- Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 SupplementationStatus unknownNCT01157780Not applicable
- Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver ToxicityCompletedNCT01149304Phase 2
- Effectiveness of ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided ProceduresCompletedNCT01148706Phase 4
- Longitudinal Study of Mitochondrial HepatopathiesSuspendedNCT01148550
- Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-BStatus unknownNCT01148277Not applicable
- Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT01147523Phase 2
- A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersCompletedNCT01146938Phase 1
- The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT01139632
- Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic ImpairmentCompletedNCT01134185Phase 1
- Role of CCL2 in Alcoholic Liver DiseasesCompletedNCT01128010
- Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic ImpairmentCompletedNCT01126086Phase 1
- Influence of Adiponutrin in Chronic Liver DiseaseCompletedNCT01122797
- Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic EncephalopathyTerminatedNCT01113567Not applicable
- Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)CompletedNCT01110577
- Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver BiopsyCompletedNCT01100398
- Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic SteatohepatitisCompletedNCT01094158Phase 2
- Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT01084486Phase 1/2
- Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT01083992Not applicable
- Screening of Patients Admitted to a Local Hospital With Pocket-sized UltrasoundCompletedNCT01081210
- Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care UnitsTerminatedNCT01079104Not applicable
- Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) PatientsWithdrawnNCT01062659
- NAFLD Pediatric Database 2CompletedNCT01061684
- Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)CompletedNCT01056133Phase 2
- The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 DiabetesActive, not recruitingNCT01047735Not applicable
- Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With EntecavirCompletedNCT01046799Phase 3
- Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular CancerCompletedNCT01034865
- Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2CompletedNCT01030484
- A Study to Assess the Effect of Hepatic Impairment on Safinamide PharmacokineticsCompletedNCT01027169Phase 1
- Bovine Colostrum for Patients With Non Alcoholic Fatty Liver DiseaseCompletedNCT01016418Phase 1/2
- A Study of TMC207 in Patients With Moderately Impaired Hepatic FunctionCompletedNCT01012284Phase 1
- Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
- Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of LifeCompletedNCT01008293Phase 2/3
- Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass SurgeryCompletedNCT01007955
- Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy SubjectsCompletedNCT01002261
- Effect of Candesartan in Alcoholic Liver FibrosisCompletedNCT00990639Phase 1/2
- Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver DiseaseStatus unknownNCT00978978Not applicable
- Remote Ischemic Preconditioning In Abdominal Organ TransplantationCompletedNCT00975702Phase 3
- Regulation of FGF21 by Nutritional ChallengesCompletedNCT00968747Not applicable
- A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic FunctionCompletedNCT00956306Phase 1
- Patient Specific Induced Pluripotency Stem Cells (PSiPS)CompletedNCT00953693
- Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis CCompletedNCT00948220Phase 4
- Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of LifeCompletedNCT00945568Not applicable
- Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT00941642Phase 4
- Uncertainty Management InterventionCompletedNCT00938795Not applicable
- Hepatocyte Matrix Implant StudyStatus unknownNCT00935454Phase 1
- Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy SubjectsCompletedNCT00931060Not applicable
- A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With PsoriasisCompletedNCT00930384
- Conditioning With Volatile Anesthetics in Liver TransplantationCompletedNCT00913276Not applicable
- Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected PersonsCompletedNCT00889577
- The Association Between Gene Polymorphisms and Infectious Complications After Liver SurgeryCompletedNCT00887887
- Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery CandidatesCompletedNCT00887393Not applicable
- Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00885313Phase 1/2
- Estimation of Functional Liver Reserve Using CholinesterasesCompletedNCT00883454
- Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery.CompletedNCT00874224Not applicable
- A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver DiseaseCompletedNCT00870077Not applicable
- Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and PrebioticsCompletedNCT00870012Not applicable
- Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver DiseaseCompletedNCT00868933Not applicable
- BG9928 in Subjects With Hepatic ImpairmentCompletedNCT00858156Phase 1
- The Connection Between Liver Disease and Chitinase ProteinsStatus unknownNCT00852293
- Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver DiseaseCompletedNCT00851981Phase 2
- Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver FunctionCompletedNCT00851227Phase 1
- Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese PatientsStatus unknownNCT00844779
- Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion ProtocolsCompletedNCT00839709
- Hepatic Impairment StudyCompletedNCT00829231Phase 1
- Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic ImpairmentCompletedNCT00828932Phase 1
- Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease PatientsStatus unknownNCT00823550Phase 4
- Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for OverweightCompletedNCT00823277
- The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT00819338Phase 2
- Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT00816465Phase 1
- Evaluation of Intestinal Microbiome in Obese KidsWithdrawnNCT00816296
- A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BStatus unknownNCT00815464Not applicable
- Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT00815009Not applicable
- Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired SubjectsCompletedNCT00812305Phase 1
- The Effect of Probiotics on Non Alcoholic Fatty Liver DiseaseTerminatedNCT00808990Phase 1
- Genetic Modifiers of Cystic Fibrosis (CF) Liver DiseaseActive, not recruitingNCT00804583
- A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal VaricesCompletedNCT00799851Phase 4
- PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT00794716Phase 2
- Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?Status unknownNCT00793195Phase 2
- Open-Label Extension of LOCKCYST TrialStatus unknownNCT00771888Phase 2/3
- Exercise Dose and Nonalcoholic Fatty Liver DiseaseCompletedNCT00771108Not applicable
- sgp130 in Chronic Human Liver DiseaseCompletedNCT00770198
- A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic ImpairmentCompletedNCT00768209Phase 1
- Colesevelam Versus Placebo in Cholestatic PruritusCompletedNCT00756171Phase 2/3
- Conjugated Hyperbilirubinemia and Pulse OximetryTerminatedNCT00741117Not applicable
- Effect of Perioperative Sivelstat Administration for Liver ResectionCompletedNCT00738348Not applicable
- TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.CompletedNCT00736905Phase 1
- Role Of Angiogenic Factors In The Development Of Hepatorenal SyndromeTerminatedNCT00734136Not applicable